Contact this trialFirst, we need to learn more about you.
Cytokine Therapy
Molgramostim for Pulmonary Alveolar Proteinosis
Recruiting2 awardsPhase 3
Cincinnati, Ohio
This trial aims to study how molgramostim can help pediatric patients aged 6 to 18 with autoimmune pulmonary alveolar proteinosis (aPAP). The study will look at how mol
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service